Emgality (Galcanezumab-gnlm PFS) 120 mg/mL x 1ml

Emgality (galcanezumab-gnlm) 120 mg/mL injection is a prescription therapy used for migraine prevention and episodic cluster headache management. This 1 mL prefilled syringe offers convenient at-home administration for adults seeking chronic pain relief. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance when using this medication.

Strength

120 mg/mL x 1ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Eli Lilly

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Emgality is prescribed to reduce the frequency of migraine headaches in adults, offering a preventive approach for those experiencing chronic attacks. It is also used to prevent episodic cluster headaches in adults, providing relief for individuals with frequent, severe headache episodes. This medication belongs to a class of therapies designed to target calcitonin gene-related peptide (CGRP) pathways.

Side Effects

Many users report a gradual reduction in the number and severity of migraine attacks after starting Emgality therapy. Some individuals may experience mild injection-site reactions, such as redness or discomfort, which typically resolve quickly. Regular use as directed may help improve daily functioning by decreasing headache-related disruptions.

Precautions & Warnings

Keep Emgality refrigerated between 2-8°C and protect from light until ready to use. Do not freeze or shake the prefilled syringe vigorously. Inspect the solution for particles or discoloration before administration; discard if any abnormalities are present. Always follow your healthcare provider’s instructions for proper disposal of used syringes.

Avoid Interactions

Emgality is a monoclonal antibody and does not undergo hepatic metabolism, reducing the risk of interactions with most medications. However, live vaccines should be avoided during treatment due to potential immune response interference. Consult your healthcare provider before starting any new medications, including over-the-counter products, to ensure compatibility.

Frequently Asked Questions

Emgality is typically administered as a monthly injection. Follow your healthcare provider’s prescribed dosing schedule for optimal results.

Inform your healthcare provider about all allergies before starting Emgality. They can assess potential risks and determine if this medication is suitable for you.

Contact your healthcare provider if you miss a dose. They will advise whether to administer the missed dose or adjust your schedule.

Weight changes are not a commonly reported effect of Emgality. Discuss any concerns with your healthcare provider during follow-up visits.

The safety of Emgality during pregnancy has not been established. Consult your healthcare provider to weigh potential risks and benefits before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.